Table of Contents

A California woman has filed a lawsuit against GlaxoSmithKline, alleging that her long-term use of Zantac caused her to develop breast cancer. According to the claim, she took brand-name Zantac and generic ranitidine products between 1997 and 2018. The lawsuit states that ranitidine exposed her to harmful levels of NDMA, a chemical linked to cancer, which she believes directly contributed to her diagnosis.

This case highlights growing concerns about the safety of Zantac and similar medications. While our firm is primarily focused on representing individuals with bladder and liver cancer claims in 2024, it’s essential for anyone affected by Zantac to understand their legal rights. If you’ve experienced health issues linked to Zantac, consult with a qualified attorney to explore your options.

Enter a 10-digit phone number with digits only (e.g., 1234567890)

By clicking the ‘Get a Free Review’ button, I hereby grant consent to be contacted at the phone number above for marketing purposes by Tort Advisor and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded message, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel. Clicking ‘Get a Free Review’ constitutes my electronic signature for authorization to be contacted and my agreement to the Terms and Conditions and [Privacy Policy]. This authorization is not required to qualify for, purchase goods, or receive services.

Partners Off-Canvas (Hidden)